iiinova — where your digital self keeps evolving

Gastro Hep Advances @aga-ghadvances.bsky.social · 30/09/2026

Not every esophageal carcinoma is what it seems. Rare ACC highlights how MYB testing can change diagnosis and management. ⬇️ 🔗 ow.ly/EKF050ZSVo4

000

Gastro Hep Advances @aga-ghadvances.bsky.social · 25/09/2026

➡️ Rare case of severe gastrointestinal graft-versus-host disease after haploidentical stem cell transplantation presenting with passage of a colonic cast, highlighting a rare GI complication. 🔗 ow.ly/XAOW50ZQEMR

010

Gastro Hep Advances @aga-ghadvances.bsky.social · 24/09/2026

➡️ Prior pancreatitis is associated with higher risks of gestational diabetes, hypertension, preterm birth, and C-section. Findings provide population-level insight into reproductive outcomes 🔗 ow.ly/x2FG50ZQBVN

000

Gastro Hep Advances @aga-ghadvances.bsky.social · 23/09/2026

➡️ In patients with ulcerative colitis in clinical remission, serum anti-integrin αVβ6 antibody levels predicted long-term relapse risk, supporting a novel treatment target. 🔗 ow.ly/966450ZQBnX 🏷️ #FeaturedArticle

000

Gastro Hep Advances @aga-ghadvances.bsky.social · 18/09/2026

📣 Meet Dr. Takeshi Saito, Associate Editor at Gastro Hep Advances! 🏛️ Keck Medicine of USC 📑 Focus in liver cell biology, antiviral immunity, and alcohol-associated + metabolic liver diseases. 🔗 ow.ly/fc1b50ZOjBW 🔬 Where scientific discovery meets clinical impact.

010

Gastro Hep Advances @aga-ghadvances.bsky.social · 18/09/2026

As #PeerReviewWeek comes to a close, GHA is proud to recognize June Tome as one of our top reviewers! From #EditorialFellow to Editorial Board Member, her dedication to peer review has helped strengthen the science we publish! Thank you, Dr. Tome! 🔗 ow.ly/hh3l50ZOsrY

000

Gastro Hep Advances @aga-ghadvances.bsky.social · 17/09/2026

CDI testing, diagnosis, and treatment differ across specialties and settings. Survey findings support physician education and universal algorithms to improve consistency of care and patient outcomes. 🔗 ow.ly/3tqK50ZOiWe 🏷️ #FeaturedArticle

011

Gastro Hep Advances @aga-ghadvances.bsky.social · 16/09/2026

The latest issue of Gastro Hep Advances is now available to read! Check out the #EditorsEssentialReading ➡️ "Glucagon-Like Peptide-1 Receptor Agonists in Inflammatory Bowel Disease: A Narrative Review" 🔗 ow.ly/gejp50ZOiKC

021

Gastro Hep Advances @aga-ghadvances.bsky.social · 10/09/2026

📣 Meet Dr. Anand S. Jain, Associate Editor at Gastro Hep Advances! 🏛️ Emory University 📑 Focus in esophageal motility disorders, integrating physiologic testing, and translational approaches 🔗 ow.ly/eLNK50ZHsVP 🔬 Where scientific discovery meets clinical impact.

010

Gastro Hep Advances @aga-ghadvances.bsky.social · 04/09/2026

As we thank Gastro Hep Advances' inaugural Board, we are equally excited to welcome our new Editorial Board and Editor-in-Chief, Dr. Anisa Shaker. Here's to the next five years of discovery, innovation, and impact! 💚 🔗 ow.ly/IOlc50ZHqRc

021

Gastro Hep Advances @aga-ghadvances.bsky.social · 02/09/2026

📂 Endoscopic evolution enabled novel management of dual gastric perforations and anastomotic dehiscence after Ivor Lewis esophagectomy, successfully treated endoscopically, avoiding surgery. 🔗 ow.ly/Morr50ZHtjj 🏷️ #CaseReport #Endoscopy

000

Gastro Hep Advances @aga-ghadvances.bsky.social · 01/09/2026

Centralized review of EGD video recordings, coupled with structured adjudication, can be implemented in large multicenter trials to provide reliable varices assessment in MASH clinical trials. 🔗 ow.ly/NPkl50ZHtf8 🏷️ #Endoscopy

000

Gastro Hep Advances @aga-ghadvances.bsky.social · 31/08/2026

💚 Thank you to the inaugural Gastro Hep Advances Board and outgoing Editors-in-Chief, Drs. Vinod Rustgi and Shanthi Srinivasan, for five years of leadership, vision, and dedication. Your work built the foundation for GHA's success and future growth. 🔗 ow.ly/sUx650ZHqrr

020

Gastro Hep Advances @aga-ghadvances.bsky.social · 28/08/2026

📣 Meet Dr. Alexandra Gutierrez, Associate Editor at Gastro Hep Advances! 🏛️ Columbia University Digestive and Liver Disease Research Center 📑 Focus in inflammatory bowel disease 🔗 ow.ly/n88150ZF01n 🔬 Where scientific discovery meets clinical impact.

010

Gastro Hep Advances @aga-ghadvances.bsky.social · 27/08/2026

📑 ColoPrep, a bidirectional text navigation program increased show rate for colonoscopy by 5.9 percentage points, based on a quasi-experimental evaluation. 🔗https://ow.ly/u6wf50ZEZNs 🏷️ #ResearchLetter

000

Gastro Hep Advances @aga-ghadvances.bsky.social · 26/08/2026

📸 Image of the Month: Elderly female w/ severe anemia, CT striking punctate intramural calcifications. Scope: abnormal mucosa, no mass. Dx: Diffuse-type gastric adenocarcinoma. Rare imaging indicative of advanced disease. 🔗 ow.ly/A57b50ZEZIv 🏷️ #Anemia #GITwitter

000

Gastro Hep Advances @aga-ghadvances.bsky.social · 25/08/2026

💚 Gastroparesis affects more than the gut. A national study found nearly 50% of hospitalized patients with gastroparesis had comorbid psychiatric disorders, underscoring the need for comprehensive, whole-person care. 🔗 ow.ly/iE1K50ZCtOv 🏷️ #GastroparesisAwarenessMonth

011

Gastro Hep Advances @aga-ghadvances.bsky.social · 21/08/2026

📣 Meet Dr. Mauricio S. Garcia, Associate Editor at Gastro Hep Advances! 🏛️ University of Arkansas for Medical Sciences 📑 Focus in alcohol-associated liver disease, liver transplantation, and hepatocellular carcinoma. 🔗 ow.ly/qyKN50ZB9ek 🔬 Where scientific discovery meets clinical impact.

010

Gastro Hep Advances @aga-ghadvances.bsky.social · 20/08/2026

➡️ Immunosuppressive therapy in #IBD requires caution. This case study involving a pregnant patient with #Crohnsdisease who developed disseminated tuberculosis with placental involvement. 🔗 ow.ly/WqY950ZB93w

000

Gastro Hep Advances @aga-ghadvances.bsky.social · 19/08/2026

✨ Check out this #FeaturedArticle from latest issue! 📑 "Breath-Based Diagnostics in Liver Diseases: Dynamic Assessment of Hepatic Metabolic Reserve and Liver Fibrosis" 🔗https://ow.ly/NkT350ZB92X

000

Gastro Hep Advances @aga-ghadvances.bsky.social · 14/08/2026

📣 Meet Dr. Mohamed I. Elsaid, Associate Editor at Gastro Hep Advances! 📑 Focus in prevention and early detection of GI diseases, including liver, colorectal, and pancreatic cancers. 🔗 ow.ly/4BEG50ZwaFG 🔬 Where scientific discovery meets clinical impact.

010

Gastro Hep Advances @aga-ghadvances.bsky.social · 13/08/2026

➡️ Endoscopic resection of a bleeding duodenal Brunner gland hamartome presenting with acute anemia. Highlights a rare but important cause of upper GI bleeding in patients without typical risk factors. 🔗 ow.ly/Wz5B50ZwEps 🏷️ #ImageoftheMonth

000

Gastro Hep Advances @aga-ghadvances.bsky.social · 12/08/2026

🗃️ Phlegmonous gastritis in a profoundly neutropenic CML patient presenting with an acute abdomen, successfully treated with topical hemostatic powder and antibiotics. 🔗 ow.ly/jXNz50ZwEiC

000

Gastro Hep Advances @aga-ghadvances.bsky.social · 12/08/2026

➡️ This study suggests that maternal diet may be a modifiable risk factor for the development of necrotizing enterocolitis, a major cause of morbidity and mortality in premature infants. 🔗 ow.ly/wrc350ZwlA9 🏷️ #GIHealth

000

Gastro Hep Advances @aga-ghadvances.bsky.social · 11/08/2026

➡️ In AF + decompensated cirrhosis, apixaban & rivaroxaban showed similar clinical outcomes. Reduced-dose apixaban was linked to higher mortality—likely confounding by indication. 🔗 ow.ly/wGIF50ZwE8H #GIHealth

000

Gastro Hep Advances @aga-ghadvances.bsky.social · 07/08/2026

🗃️ Pre-operative diagnosis of the rare IMHMV in a post-liver transplant patient. 🔗 ow.ly/LBuk50ZwClu 🏷️ #CaseReport #LiverTransplant #Endoscopy

000

Gastro Hep Advances @aga-ghadvances.bsky.social · 06/08/2026

🚨 Up to one in four U.S. Veterans with primary biliary cholangitis have already progressed to cirrhosis at time of diagnosis. Greater awareness of timely diagnosis and treatment of PBC is critical. 🔗 ow.ly/aE2J50ZwCcO 🏷️ #Cirrhosis #Veterans

001

Gastro Hep Advances @aga-ghadvances.bsky.social · 05/08/2026

➡️ A new clustering-based machine learning model predicts 30-day mortality in GI bleeding (AUC 0.88 on external validation, n=7,166), outperforming traditional risk scores. 🔗 ow.ly/cLZZ50ZwBYB 🏷️ #GIbleeding #AI

010

Gastro Hep Advances @aga-ghadvances.bsky.social · 04/08/2026

📣 Meet Dr. Anisa Shaker, the new Editor-in-Chief of Gastro Hep Advances! We’re thrilled to welcome her leadership and expertise as we enter an exciting new chapter for the journal. 🔗 ow.ly/abcW50Zw9Hk 🔬 Where scientific discovery meets clinical impact.

010

Gastro Hep Advances @aga-ghadvances.bsky.social · 30/07/2026

📇 Early results suggest an engineered microbial lipase could offer a new non-porcine treatment for exocrine pancreatic insufficiency, improving fat absorption with a favorable safety profile. 🔗 ow.ly/72Ry50Ztx9m 🏷️ #GIHealth

111

Gastro Hep Advances @aga-ghadvances.bsky.social · 29/07/2026

📑 Bilirubin-driven phenotype in severe alcohol-associated hepatitis predicts higher 90-day mortality despite similar MELD, highlighting disease heterogeneity. 🔗 ow.ly/EwsL50Ztx0J 🏷️ #Hepatitis #LiverHealth

000

Gastro Hep Advances @aga-ghadvances.bsky.social · 28/07/2026

➡️ This study demonstrates successful colorectal ESD at a rural U.S. community hospital, with favorable outcomes, expanding access beyond tertiary centers and contributing to limited U.S. ESD data. 🔗 ow.ly/yHxI50ZtwUI 🏷️ #ColonCancer #GIHealth

000

Gastro Hep Advances @aga-ghadvances.bsky.social · 17/07/2026

MASLD affects quality of life in people with HIV. 🔹 Worse physical functioning 🔹 More fatigue 🔹 Greater metabolic burden→worse outcomes 👉 MASLD is a patient-centered issue, not just a liver diagnosis 🔗https://ow.ly/k11150Zo1S8 🏷️ #MASLD #HIV #FeaturedArticle

000

Gastro Hep Advances @aga-ghadvances.bsky.social · 16/07/2026

🎉 The newest issue of Gastro Hep Advances is here! Check out the Editor's Essential Reading! ⭐ "The Gut-Brain Axis—From Science to Clinical Practice" 🔗 ow.ly/KRnn50Zo1PS 🏷️ #GutBrainAxis #GIHealth #NarrativeReview

010

Gastro Hep Advances @aga-ghadvances.bsky.social · 02/07/2026

⬇️ A comprehensive review of 20 case reports (1983–2024) examining clinical presentation, diagnostic approach, complications, and therapeutic strategies in Genital Crohn’s Disease. 🔗 ow.ly/eBvi50ZitNL 🏷️ #CaseReports #CrohnsDisease

000

Gastro Hep Advances @aga-ghadvances.bsky.social · 01/07/2026

New meta-analysis shows that adding PD-(L)1 inhibitors to chemotherapy improves survival in advanced gastric and gastroesophageal junction cancer—consistently in both Asian and non-Asian patients. 🔗 ow.ly/INt550ZitLO 🏷️#StomachCancer #GI

000

Gastro Hep Advances @aga-ghadvances.bsky.social · 30/06/2026

UF+CCF-authored review highlights clinical significance of fatty pancreas, its links to metabolic dysfunction & pancreatic cancer, plus fresh advances in imaging and surgical management for clinicians. 🔗 ow.ly/Xv3o50ZitJt 🏷️ #Pancreas #GI

000

Gastro Hep Advances @aga-ghadvances.bsky.social · 19/06/2026

📑 This paper aimed to investigate the correlation between neutrophil- or monocyte-associated factors and the therapeutic response to Granulocyte/monocyte absorption apheresis in patients with intractable UC. 🔗 ow.ly/sx1250Zc3cW 🏷️ #UlcerativeColitis #FeaturedArticle

000

Gastro Hep Advances @aga-ghadvances.bsky.social · 18/06/2026

GHA has received a 2025 Impact Factor of 3.3! On behalf of Editors-in-Chief Shanthi Srinivasan & Vinod K. Rustgi, thank you to our editors, authors, reviewers, and readers for your continued support. ow.ly/tnlP50ZeoiV Nikki Duong MD American Gastroenterological Association (AGA)

ow.ly

Just released: AGA journals receive new Impact Factor scores

The American Gastroenterological Association (AGA) is the trusted voice of the GI community. AGA publishes top-tier journals, guidelines and patient education ...

010

Gastro Hep Advances @aga-ghadvances.bsky.social · 18/06/2026

⭐ Check out this narrative review ➡️ "Refractory Ascites and the Alfapump" 🔗 ow.ly/S3Qa50Zc36t 🏷️ #FeaturedArticle #NarrartiveReview #GIHealth

000

Gastro Hep Advances @aga-ghadvances.bsky.social · 17/06/2026

🩸 Blood biomarkers modestly improved prediction of high-risk adenomas (AUC 0.66) and may help better target colonoscopy resources. 🔗 ow.ly/h7em50Zc2XA 🏷️ #EditorsEssentialReading #Colonoscopy

010

Gastro Hep Advances @aga-ghadvances.bsky.social · 16/06/2026

📣 The newest issue of Gastro Hep Advances is here! Check it out ➡️ www.ghadvances.org/issue/S2772-5723… 🏷️ #GIHealth

000

Gastro Hep Advances @aga-ghadvances.bsky.social · 11/06/2026

📋 Upadacitinib improved clinical, endoscopic, and histologic outcomes in 3 patients with refractory esophageal lichen planus after failure of steroids, immunosuppressants, and dilations. 🔗 ow.ly/Q3l450Z94Ll 🏷️ #ResearchLetter #GIHealth

000

Gastro Hep Advances @aga-ghadvances.bsky.social · 10/06/2026

Modeling shows that reallocating colonoscopies in the US ➡️ from CRC screening to follow-up after positive stool-based tests ➡️ while maintaining full capacity may detect & prevent more CRC & reduce costs. 🔗 ow.ly/tu4j50Z94J3 🏷️ #CRC #Endoscopy

000

Gastro Hep Advances @aga-ghadvances.bsky.social · 09/06/2026

📑 This study tested whether AI can classify biopsy tissue in pediatric inflammatory bowel disease slides, detecting abnormal tissue, inflammation, and chronic changes in pathology images. 🔗 ow.ly/FBmz50Z94HJ 🏷️ #IBD #AI

000

Gastro Hep Advances @aga-ghadvances.bsky.social · 28/05/2026

🖥️ Screen-detected #CeliacDisease patients may have fewer symptoms but similar disease severity vs clinically diagnosed cases, with both groups improving on a gluten-free diet ➡️ Highlights the potential value of early detection in #CeliacDisease 🔗 ow.ly/WveA50YWFLB

000

Gastro Hep Advances @aga-ghadvances.bsky.social · 27/05/2026

⭐ New study showed variability in how dietitians manage the low FODMAP reintroduction phase. Practices differ in dosing, timing, and follow-up, underscoring the need for standardized clinical protocols. 🔗 ow.ly/1iEM50Z4vJH

000

Gastro Hep Advances @aga-ghadvances.bsky.social · 25/05/2026

One image can change everything ❤️‍🩹 a diagnosis, a decision, a patient’s story 👨‍⚕️Share yours as Image of the Month in Gastro Hep Advances: 🧾Striking images + a concise 200-word clinical story that challenges and teaches 📮Submit today ➡️ ow.ly/UWPa50YYrwL 🏷️ #OpenAccess

000

Gastro Hep Advances @aga-ghadvances.bsky.social · 23/05/2026

🖥️ Screening for #LiverCancer using AFP and ultrasound scans: rising incidence and detection rates, but with same survival rates. Criteria for screening and palliation should be revised. 🔗 ow.ly/QoUr50Z1S8X 🏷️ #LiverHealth #FeaturedArticle

010

Gastro Hep Advances @aga-ghadvances.bsky.social · 22/05/2026

hCLiP-derived small extracellular vesicles (sEVs) exert anti-fibrotic effects via their miRNA cargo. This study suggests a promising cell-free therapy for liver fibrosis. 🔗 ow.ly/8Pjt50Z1S0G 🏷️ #LiverFibrosis #sEVs

000